These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7308667)

  • 1. Metabolic fate of N, N-dipropylnitrosamine and N, N-diamylnitrosamine in the rat, in relation to their lack of carcinogenic effect on the urinary bladder.
    Suzuki E; Okada M
    Gan; 1981 Aug; 72(4):552-61. PubMed ID: 7308667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder.
    Suzuki E; Aoki J; Okada M
    Gan; 1981 Aug; 72(4):547-51. PubMed ID: 7308666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic fate of N,N-dibutylnitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine homologs in the rat, in relation to their organotropic carcinogenicity to the urinary bladder.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Feb; 72(1):113-22. PubMed ID: 7274637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic fate of asymmetric N,N-dialkylnitrosamines having butyl group in the rat.
    Suzuki E; Okada M
    Gan; 1981 Dec; 72(6):910-20. PubMed ID: 7341340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Suzuki E; Okada M
    Gan; 1980 Dec; 71(6):856-62. PubMed ID: 7274630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats.
    Okada M; Suzuki E; Hashimoto Y
    Gan; 1976 Dec; 67(6):825-34. PubMed ID: 191321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of N-alkyl-N-(3-hydroxypropyl and 2-hydroxy-ethyl)nitrosamines in the rat in relation to the induction of bladder cancer by N-butyl-N-(4-hydroxybutyl)nitrosamine and its homologs.
    Suzuki E; Iiyoshi M; Okada M
    Gan; 1981 Apr; 72(2):254-8. PubMed ID: 7286549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate of n-methyl-N-dodecylnitrosamine in the rat, in relation to its carcinogenicity to the urinary bladder.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1981 Oct; 72(5):713-6. PubMed ID: 7327371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. Selective induction of urinary bladder tumours in the rat.
    Okada M; Ishidate M
    Xenobiotica; 1977; 7(1-2):11-24. PubMed ID: 191997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis.
    Suzuki E; Anjo T; Aoki J; Okada M
    Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of omega-1 and omega-2 oxidized N-nitrosodibutylamines in the rat.
    Suzuki E; Okada M
    Jpn J Cancer Res; 1985 Mar; 76(3):173-83. PubMed ID: 3922835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure and metabolic fate of N-nitrosodialkylamines in relation to their organotropic carcinogenicity with special reference to induction of urinary bladder tumors].
    Mochizuki M; Suzuki E; Okada M
    Yakugaku Zasshi; 1997 Nov; 117(10-11):884-94. PubMed ID: 9414598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okada M; Suzuki E; Iiyoshi M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3909-13. PubMed ID: 747858
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds.
    Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y
    Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat.
    Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C
    Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-dibutylnitrosamine metabolism by rat liver S9 fraction and oxidation by chemical model systems.
    Suzuki E; Mochizuki M; Shibuya K; Okada M
    Gan; 1983 Feb; 74(1):41-50. PubMed ID: 6341154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumors in the liver, urinary bladder, esophagus and forestomach by short-term treatment with different doses of N,N'-dibutylnitrosamine in rats.
    Tsuda H; Mera Y; Seki K; Aoki T; Fukushima S; Ito N
    Jpn J Cancer Res; 1987 Mar; 78(3):227-34. PubMed ID: 2883167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.